The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
- Sungho Maeng
- , Carlos A. ZarateJrAffiliated with10 Center Drive, CRC Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In this article, we first review a study showing that the N-methyl-d-aspartate (NMDA) receptor antagonist ketamine leads to rapid, robust, and relatively sustained antidepressant effects in patients with treatment-resistant major depression. We then discuss our hypothesis that the therapeutic effects of monoaminergic antidepressants and ketamine may be mediated by increased AMPA-to-NMDA glutamate receptor throughput in critical neuronal circuits. We hypothesize that ketamine directly mediates this throughput, whereas monoaminergic antidepressants work indirectly and gradually; this may explain, in part, the lag of onset of several weeks to months that is observed with traditional antidepressants.
- The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
Current Psychiatry Reports
Volume 9, Issue 6 , pp 467-474
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links